Creation of a gated antibody as a conditionally functional synthetic protein

Nature Communications

Volumn 5, Issue , 2014, Pages

  Gunnoo, Smita B ^a   Finney, Helene M ^b   Baker, Terry S ^b   Lawson, Alastair D ^b   Anthony, Daniel C ^a   Davis, Benjamin G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ANTIGEN; PROTEIN; ANTIBODY; LYSOZYME; PROTEIN BINDING;

ANTIBODY; BIOMARKER; CELL ORGANELLE; ENZYME ACTIVITY; PHOSPHORUS; PROTEIN;

ACCURACY; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMAL; MODULATION; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECOGNITION; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; SYNTHESIS;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CHEMISTRY TECHNIQUES, SYNTHETIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; IN VITRO TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MURAMIDASE; PHOSPHORYLATION; PROTEIN BINDING;

EID: 84905259142     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5388     Document Type: Article

References (38)

1. Canton, B., Labno, A. & Endy, D. Refinement and standardization of synthetic biological parts and devices. Nat. Biotechnol. 26, 787-793 (2008). (Pubitemid 351961452)
2. Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339-342 (2000). (Pubitemid 30062394)
3. Salis, H. & Kaznessis, Y. N. Computer-aided design of modular protein devices: Boolean AND gene activation. Phys. Biol. 3, 295-310 (2006). (Pubitemid 46646260)
4. Lu, T. K., Khalil, A. S. & Collins, J. J. Next-generation synthetic gene networks. Nat. Biotech. 27, 1139-1150 (2009).
5. Wang, B. J., Kitney, R. I., Joly, N. & Buck, M. Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology. Nat. Commun. 2, 508 (2011).
6. Bonnet, J., Yin, P., Ortiz, M. E., Subsoontorn, P. & Endy, D. Amplifying genetic logic gates. Science 340, 599-603 (2013).
7. Siuti, P., Yazbek, J. & Lu, T. K. Synthetic circuits integrating logic and memory in living cells. Nat. Biotech. 31, 448-452 (2013).
8. Mahdavi, A. et al. A genetically encoded AND gate for cell-targeted metabolic labeling of proteins. J. Am. Chem. Soc. 135, 2979-2982 (2013).
9. Ding, M. et al. The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy. Cancer Gene Ther. 19, 382-392 (2012).
10. Douglas, S. M., Bachelet, I. & Church, G. M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831-834 (2012).
11. Bray, D. Protein molecules as computational elements in living cells. Nature 376, 307-312 (1995).
12. Pearlman, S. M., Serber, Z. & Ferrell, J. E. A mechanism for the evolution of phosphorylation sites. Cell 147, 934-946 (2011).
13. Chalker, J. M., Bernardes, G. J. L. & Davis, B. G. A 'tag-and-modify' approach to site-selective protein modification. Acc. Chem. Res. 44, 730-741 (2011).
14. Chalker, J. M. et al. Methods for converting cysteine to dehydroalanine on peptides and proteins. Chem. Sci. 2, 1666-1676 (2011).
15. Hamerscasterman, C. et al. Naturally-occurring antibodies devoid of lightchains. Nature 363, 446-448 (1993).
16. Desmyter, A. et al. Crystal structure of a camel single-domain V-H antibody fragment in complex with lysozyme. Nat. Struct. Biol. 3, 803-811 (1996). (Pubitemid 26303407)
17. Tarrant, M. K. & Cole, P. A. The chemical biology of protein phosphorylation. Annu. Rev. Biochem. 78, 797-825 (2009).
18. Gallego, M. & Virshup, D. M. Protein serine/threonine phosphatases: life, death, and sleeping. Curr. Opin. Cell. Biol. 17, 197-202 (2005). (Pubitemid 40380944)
19. Sun, F. et al. Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance. Proc. Natl Acad. Sci. USA 109, 15461-15466 (2012).
20. Berger, J., Hauber, J., Hauber, R., Geiger, R. & Cullen, B. R. Secreted placental alkaline-phosphatase-a powerful new quantitative indicator of geneexpression in eukaryotic cells. Gene 66, 1-10 (1988).
21. Doronin, K. K. et al. Expression of the gene encoding secreted placental alkaline-phosphatase (SEAP) by a nondefective adenovirus vector. Gene 126, 247-250 (1993).
22. Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9, 361-371 (2009).
23. Harmsen, M. M. & Haard, H. J. D. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13-22 (2007). (Pubitemid 47573319)
24. Rothbauer, U. et al. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 3, 887-889 (2006). (Pubitemid 44614722)
25. Kirchhofer, A. et al. Modulation of protein properties in living cells using nanobodies. Nat. Struct. Mol. Biol. 17, 133-138 (2010).
26. Lin, M. F. et al. Regulation of prostatic acid-phosphatase expression and secretion by androgen in lncap human prostate carcinoma-cells. Arch. Biochem. Biophys. 300, 384-390 (1993).
27. Adams, L. M., Warburton, M. J. & Hayman, A. R. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP). Cell Biol. Int. 31, 191-195 (2007). (Pubitemid 46187104)
28. Donaldson, J. M., Kari, C., Fragoso, R. C., Rodeck, U. & Williams, J. C. Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies. Cancer Biol. Ther. 8, 2147-2152 (2009).
29. Bernacki, R. J., Niedbala, M. J. & Korytnyk, W. Glycosidases in cancer and invasion. Cancer Metastasis Rev. 4, 81-101 (1985).
30. Macauley, M. S., Stubbs, K. A. & Vocadlo, D. J. O-GlcNAcase catalyzes cleavage of thioglycosides without general acid catalysis. J. Am. Chem. Soc. 127, 17202-17203 (2005). (Pubitemid 41791036)
31. Niculescu-Duvaz, I. & Springer, C. J. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Adv. Drug Deliv. Rev. 26, 151-172 (1997). (Pubitemid 27289531)
32. Larson, R. A. et al. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 104, 1442-1452 (2005). (Pubitemid 41356159)
33. Dueber, J. E., Yeh, B. J., Chak, K. & Lim, W. A. Reprogramming control of an allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003). (Pubitemid 37221395)
34. Arkin, A. & Ross, J. Compuational functions in biochemical reaction networks. Biophys. J. 67, 560-578 (1994). (Pubitemid 24235385)
35. Unger, R. & Moult, J. Towards computing with proteins. Proteins 63, 53-64 (2006).
36. Holliger, P. & Winter, G. Engineering bispecific antibodies. Curr. Opin. Biotechnol. 4, 446-449 (1993). (Pubitemid 23250384)
37. Anthony, D. C. et al. Matrix metalloproteinase expression in an experimentallyinduced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87, 62-72 (1998). (Pubitemid 28319845)
38. Couch, Y., Alvarez-Erviti, L., Sibson, N. R., Wood, M. J. A. & Anthony, D. C. The acute inflammatory response to intranigral alpha-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J. Neuroinflammation 8, 166 (2011).